Top Page | English | 简体中文 | 繁體中文 | 한국어 | 日本語
  Press Releases
Thursday, August 1, 2019
Eisai to Refresh and Launch Sahne Cream After 20 Years with Mild Scent and New Package
Tuesday, July 23, 2019
Eisai and Merck & Co., Inc., Kenilworth, N.J., U.S.A. Receive Breakthrough Therapy Designation from FDA
Friday, July 19, 2019
Eisai Presented Latest Trends of Treatment for Alzheimer's at AAIC 2019
Eisai Presented Data Showing Quantification of Tau Microtubule Binding Region at AAIC 2019
Thursday, July 18, 2019
Eisai Presents Research Evaluating Correlation of Highly-Precisely Measured Amyloid Beta in Plasma and Cerebrospinal Fluid with Newly Developed Automated Protein Assay System at AAIC 2019
Eisai Presents Nonclinical Research Results of Elenbecestat at AAIC 2019
Wednesday, July 17, 2019
Eisai's Anticancer Agent Halaven Approved for Treatment of Locally Advanced or Metastatic Breast Cancer in China
Thursday, July 11, 2019
Eisai Listed for 18th Consecutive Year in FTSE4Good Index Series
Latest Data on Eisai's Alzheimer's Disease/ Dementia Pipeline to be Presented at AAIC 2019
Wednesday, July 10, 2019
Eisai Center for Genetics Guided Dementia Discovery Commences Full-Scale Operation Toward Innovative Dementia Treatments With New Drug Discovery Approach in Cambridge, Massachusetts

Copyright © 2019 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 800 291 0906 | Beijing: +86 400 879 3881 | Hong Kong: +852 2217 2912 | Singapore: +65 6304 8926 | Tokyo: +81 3 6859 8575

Connect With us: